Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10479803 Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors

Patent 10479803 was granted and assigned to Incyte on November, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Incyte

Current Assignee

Incyte

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10479803

Date of Patent

November 19, 2019

Patent Application Number

16112174

Date Filed

August 24, 2018

Patent Citations

‌

US Patent 10092570 Heterocyclylamines as PI3K inhibitors

‌

US Patent 10077277 Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors

‌

US Patent 10125150 Crystalline forms of a PI3K inhibitor

Patent Citations Received

‌

US Patent 12024522 Salts and processes of preparing a PI3K inhibitor

‌

US Patent 11819505 Heterocyclylamines as PI3K inhibitors

‌

US Patent 11433071 Heterocyclylamines as PI3K inhibitors

‌

US Patent 11999751 Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors

‌

US Patent 10829502 Pyrimidinones as PI3K inhibitors

‌

US Patent 11304949 Treatment of hidradenitis suppurativa using JAK inhibitors

‌

US Patent 11401280 Pyrimidinones as PI3K inhibitors

Patent Primary Examiner

‌

Theodore R West

Patent abstract

This application relates to derivatives of Formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10479803 Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API